GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hisamitsu Pharmaceutical Co Inc (OTCPK:HTSUY) » Definitions » EV-to-FCF

HTSUY (Hisamitsu Pharmaceutical Co) EV-to-FCF : (As of Dec. 13, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Hisamitsu Pharmaceutical Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Hisamitsu Pharmaceutical Co's Enterprise Value is $1,286 Mil. Hisamitsu Pharmaceutical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Aug. 2024 was $0 Mil. Therefore, Hisamitsu Pharmaceutical Co's EV-to-FCF for today is .

The historical rank and industry rank for Hisamitsu Pharmaceutical Co's EV-to-FCF or its related term are showing as below:

HTSUY' s EV-to-FCF Range Over the Past 10 Years
Min: 27.87   Med: 35.33   Max: 40.8
Current: 36.75

During the past 13 years, the highest EV-to-FCF of Hisamitsu Pharmaceutical Co was 40.80. The lowest was 27.87. And the median was 35.33.

HTSUY's EV-to-FCF is ranked worse than
62.61% of 551 companies
in the Drug Manufacturers industry
Industry Median: 25.85 vs HTSUY: 36.75

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-13), Hisamitsu Pharmaceutical Co's stock price is $7.085. Hisamitsu Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Aug. 2024 was $0.325. Therefore, Hisamitsu Pharmaceutical Co's PE Ratio (TTM) for today is 21.80.


Hisamitsu Pharmaceutical Co EV-to-FCF Historical Data

The historical data trend for Hisamitsu Pharmaceutical Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hisamitsu Pharmaceutical Co EV-to-FCF Chart

Hisamitsu Pharmaceutical Co Annual Data
Trend Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.82 215.59 10.23 34.13 33.47

Hisamitsu Pharmaceutical Co Quarterly Data
Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 33.47 - -

Competitive Comparison of Hisamitsu Pharmaceutical Co's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Hisamitsu Pharmaceutical Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hisamitsu Pharmaceutical Co's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hisamitsu Pharmaceutical Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Hisamitsu Pharmaceutical Co's EV-to-FCF falls into.



Hisamitsu Pharmaceutical Co EV-to-FCF Calculation

Hisamitsu Pharmaceutical Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=1286.286/0
=

Hisamitsu Pharmaceutical Co's current Enterprise Value is $1,286 Mil.
Hisamitsu Pharmaceutical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Aug. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hisamitsu Pharmaceutical Co  (OTCPK:HTSUY) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Hisamitsu Pharmaceutical Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=7.085/0.325
=21.80

Hisamitsu Pharmaceutical Co's share price for today is $7.085.
Hisamitsu Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Aug. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.325.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Hisamitsu Pharmaceutical Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Hisamitsu Pharmaceutical Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Hisamitsu Pharmaceutical Co Business Description

Traded in Other Exchanges
Address
408 Tashiro Daikan-machi, Tosu, Saga, JPN, 841-0017
Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.

Hisamitsu Pharmaceutical Co Headlines

No Headlines